US HB3793 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on June 5 2023 - 25% progression
Action: 2023-06-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 5 2023 - 25% progression
Action: 2023-06-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to require manufacturers of life-saving drugs to submit data and information to assess the stability of the drugs and determine their longest supported expiration date, and for other purposes.
Title
Ensuring Access to Lifesaving Drugs Act of 2023
Sponsors
| Rep. Elissa Slotkin [D-MI] | Rep. Scott Peters [D-CA] | Rep. John Sarbanes [D-MD] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-09 | House | Referred to the Subcommittee on Health. |
| 2023-06-05 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-06-05 | House | Introduced in House |
Same As/Similar To
HB4697 (Related) 2023-07-21 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/3793/all-info |
| Text | https://www.congress.gov/118/bills/hr3793/BILLS-118hr3793ih.pdf |
